Board Appraisals - From Compliance to Success


Many organisations approach board appraisal as something difficult and boring, but, it doesn’t have to be that way. A successful board appraisal can not only be interesting, but also add significant value to an organisation by helping poor-performing boards sort out problems and the better ones get better.

An unsuccessful appraisal can at best be a waste of valuable time, at worst destructive. This article by Professor Sir Andrew Likierman, the Dean of London Business School, explores the basis for measuring that success.

The article includes comments from Peter Waine, a Criticaleye Associate and Partner at Hanson Green.

Share this with your Community



Contributor
Peter Waine
Board Mentor
Criticaleye


Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

BLOG | Human Capital at the Crossroad

Artificial intelligence, geopolitical instability and sustained economic uncertainty are reshaping the human capital agenda and placing new demands on Boards. Workforce models, skills requirements, talent strategies ...


How to Execute a Successful Exit with Paul Lester CBE

A successful exit is rarely defined by valuation alone. Behind every strong outcome is strategic preparation, disciplined leadership and an organisation that is ready for transition. In this episode of Criticaley...


Click here to download this insight

BLOG | The CEO-CFO Partnership: Driving Strategic Alignment

The relationship between the CEO and CFO has never been more important.  In a business environment defined by economic uncertainty, AI-driven transformation and heightened stakeholder expe...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 205




Legal & General Global Payments E.ON UK Rolls-Royce AlixPartners Hitachi Solutions Mayborn Group Drax Group plc Lightsource bp LACE Partners British Land NATS NatWest Group London Stock Exchange Group Stream GlaxoSmithKline plc